© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
178489 |
As an accredited 5-Bromo-1,3-Dihydrobenzimidazol-2-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-1,3-Dihydrobenzimidazol-2-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Many laboratories face the same challenge: picking chemical intermediates that balance purity, stability, and versatility. Here, 5-Bromo-1,3-Dihydrobenzimidazol-2-One stands out. This compound, recognized by its structure as a brominated benzimidazolone, makes a clear mark in specialty chemical synthesis. Researchers seeking a robust building block appreciate its unique molecular configuration. Its model formula, C7H5BrN2O, sets it apart from other halogenated benzimidazoles, offering a precise fit for routes that demand systematic bromine incorporation.
From my own experience, the structure influences not just reactivity, but also practical workflow. 5-Bromo-1,3-Dihydrobenzimidazol-2-One contains a bromine atom positioned at the 5th carbon on the aromatic ring. Unlike broader-spectrum benzimidazolones or other halogen substitutions, this pattern gives reactions a higher level of predictability. Many chemists notice the difference in coupling yields and selectivity right away compared to, say, florinated counterparts or unsubstituted benzimidazolones. Density sits roughly at 1.8 g/cm3 and a melting range between 180°C and 185°C keeps the material stable through most workups, from traditional heating baths to automated synthesis rigs.
Bringing this compound into play often unlocks new routes in small molecule design and pharmaceuticals. That bromine atom isn't just decoration. It acts as a powerful leaving group or target for cross-coupling, Suzuki reactions, or aromatic substitution. Anyone working in medicinal chemistry sees how precise halogen positions affect downstream bioactivity, pharmacokinetics, or protein-ligand fit. 5-Bromo-1,3-Dihydrobenzimidazol-2-One helps projects avoid the trial-and-error seen with less targeted benzimidazoles. So if you’re after kinase inhibitors, antimicrobial scaffolds, or high-affinity probe design, the molecule fills a key space in your toolkit.
Chemists know that even a minor impurity or hygroscopic effect can derail a synthesis. This product arrives as an off-white to beige solid, compact enough for safe storage and reliable measurement. It resists atmospheric moisture, so jars don't clump or cake up after a week on the shelf. That's a difference you only notice after losing too many batches to inconsistency with other benzimidazole analogs that absorb water or oxidize under room light. I’ve worked with batches that held their specs after five months, so longevity really matches claims on the datasheet.
Kind of like bringing a well-cut tool into your shop, this compound adds a real edge. Its selectivity stands out. By contrast, unsubstituted benzimidazolones make for dull additions in complex frameworks, with limited handles for derivatization. 5-Bromo-1,3-Dihydrobenzimidazol-2-One’s carefully considered substitution enhances downstream modifications, allowing specific linkers or labels to attach where chemists want them—not somewhere random on the molecule. This saves time and solvent costs. Stability also makes a huge difference. Some other halogenated versions lose punch after a few cycles, especially with higher temperatures or strong base conditions.
Drug discovery builds around small but critical choices. Selective intermediates prevent wasted effort. A well-positioned bromine unlocks late-stage diversification, letting discovery teams spin out libraries without wasting months on failed routes. I’ve seen researchers use this molecule's structure in fragment-based screening, tweaking it for assorted enzyme targets. Bromine’s size and electronic effects can sharply increase hit rates with protein pockets meant to anchor aromatic rings. The compound also sees use as a precursor for benzimidazole-based ligands in ion channel studies, anti-cancer exploratory compounds, and enzyme inhibitors.
Not every lab works on drugs. 5-Bromo-1,3-Dihydrobenzimidazol-2-One steps up in polymer research, specialty dyes, and organic semiconductors. That bromo handle becomes a gateway to tailored functionalities, so materials scientists can adjust electrical and mechanical properties with a single coupling. Stable aromatic platforms like this one endure under heat and electrical bias, where many simple benzimidazolones crumble or lose their features. Some research groups have shown benzimidazole derivatives, especially brominated ones, driving advances in light-emitting materials and charge-transporting frameworks. There aren't too many options that deliver this kind of dual role—serving both health sciences and advanced materials—without high cost or sourcing headaches.
Too often, researchers settle for what’s on the shelf, even if yields and purity suffer. Comparing 5-Bromo-1,3-Dihydrobenzimidazol-2-One with similar compounds, the benefits surface pretty quickly. Take 5-Chloro-1,3-dihydrobenzimidazol-2-one, for instance. Chlorine, being a smaller atom, often delivers lower selectivity and different reactivity in coupling and nucleophilic substitution. The bromo variant opens up more palladium-catalyzed transformations and lets you reach a wider scope of end-products. Compared to non-substituted or methylated benzimidazolones, the 5-bromo version serves synthetic flexibility and target specificity. Those working in chemical biology see their molecule stick to a biomolecule at the intended spot, not wanding off to a side pathway or metabolic dead end.
Pharmaceutical startups and established labs alike use this compound to streamline scale-up and lead optimization. Medicinal chemists seeking SAR (structure-activity relationship) data value how fast they can slot analogs into their pipeline without running new synthetic routes every time. Researchers in peptide conjugates often struggle with selective activation; adding a bromo-benzo ring at the 5-position enables efficient attachment strategies without risking cleavage or degradation at adjacent sites. Peptide therapies, for example, can gain new delivery mechanisms or modified half-lives by running linkers using this compound.
In regulated sectors, having documentation and traceable analytics gives teams confidence. Quality matters in preclinical runs, scale-up, and published studies. Typically, this compound arrives with purity above 98%, with HPLC data backing the claim. Labs aiming for grant funding or publication put trust in transparent supply chains—right down to NMR and MS traceability. Impurity profiles look cleaner than lots of cheaper benzimidazolones from poorly managed suppliers, which saves time during product isolation and downstream analysis. Anyone missing a deadline over a bad batch knows the value here.
Many chemists now juggle sustainability with efficiency, looking for ways to minimize waste and reduce the use of toxic reagents. 5-Bromo-1,3-Dihydrobenzimidazol-2-One lends itself to greener processes. Its good reactivity enables milder reaction conditions, lessening the need for excessive catalysts or high temperatures. Labs working under strict emission and waste mandates appreciate not needing to repeat reactions just to get a decent yield. On the user safety front, this material gives off little dust, doesn’t release hazardous vapors in typical usage, and resists degradation except under pretty extreme lab conditions.
Most researchers watch budgets pretty closely, so affordability always factors in. For what you get, this compound seems well-priced. While specialty chemicals with exotic substitutions rocket up in cost, 5-Bromo-1,3-Dihydrobenzimidazol-2-One brings serious value, enabling libraries of analogs without blowing up project estimates. Even small labs or academic groups can routinely access it in gram to kilogram scales. So graduate students can afford to make mistakes, learn, and move forward, which matters more than any theoretical yield.
Chasing high selectivity and yield without destroying the starting material or byproduct profile can become a mess. Many routes using standard benzimidazolones stall out or require complex protecting group strategies—wasting time and materials. The 5-bromo group simplifies late-stage modifications, a recurring pain point with other analogs that don't offer any meaningful handle for cross-coupling. In real-world practice, this results in cleaner workups, fewer competing reactions, and much less fiddling with purification steps. I’ve seen teams cut synthesis times by a week or more just by switching to this compound for their halogen handle.
With the pace of therapeutic innovation, every shortcut that doesn’t sacrifice quality can mean faster entry to clinical stages. The compound’s compatibility with high-throughput platforms makes it a favorite for teams running hundreds of synthetic runs a week. Entry-level researchers can quickly get up to speed, and senior scientists can bank on reliable, reproducible outcomes. This not only saves money, but also builds data sets strong enough to support patent claims or regulatory submissions.
What keeps this compound in favor is the sum of its working benefits—clarity in reactivity, batch stability, selective modification, and practical handling. Knowledge grows in efficient labs; scientists using well-characterized intermediates like this spend less time troubleshooting mystery issues. If your group often struggles with hit-or-miss intermediates or batch-to-batch mystery variables, switching can dry up many of those performance-robbing surprises.
I’ve also seen this compound make waves in environmental chemistry and diagnostic development, two fields not usually associated with benzimidazolone derivatives. As a coupling partner in surface functionalization, it offers a pathway to solid-phase supports that won’t degrade under moderate UV or oxidizing conditions. In sensor research, bromo-substituted benzimidazolones are now being investigated for integration into photon-detecting frameworks, where their stable aromatic structure gives both longevity and precision signal readout.
No product stands without room for growth, and 5-Bromo-1,3-Dihydrobenzimidazol-2-One is no exception. Supply can tighten for large projects, especially if raw material markets wobble. Researchers who need kilo-quantities for custom runs might still find themselves waiting weeks for restock if global sources face bottlenecks. The path forward points to expanding reliable supply lines and educating smaller suppliers on best-practice purification.
The story behind every successful molecule is built on steady hands—manufacturers who understand the fine details, researchers who share their hurdles, and community feedback turning into better next-gen products. Broader community sharing around real-use results, not just published data, can accelerate improvements. Labs pooling their results, including failures and oddball results, raise collective knowledge, prompting process changes or triggering new approaches to purification or storage.
To me, compounds like 5-Bromo-1,3-Dihydrobenzimidazol-2-One make a difference by turning what used to be high-barrier chemistry into accessible, repeatable methods. As open-source science and data transparency pick up speed, this compound looks set to play a bigger role. With more analytics, user feedback, and global access, chemistry pushes forward—the everyday details of versatile, approachable intermediates matter just as much as the big discoveries they help support.
The shift toward evidence-based selection—where teams verify claims with independent HPLC traces, reliable NMR peaks, and hands-on yield data—keeps hype out and results in. Over the years, I've lost patience with overhyped intermediates that underdeliver in real experiments. In contrast, the value here rests solidly on reproducible numbers, sharp analytical results, and good lab experiences. That keeps 5-Bromo-1,3-Dihydrobenzimidazol-2-One circulating across disciplines and explains why more groups list it in their reference libraries.
In the end, good chemistry is about hard evidence, shared data, clear advantages, and work that stands up to the test of replication. 5-Bromo-1,3-Dihydrobenzimidazol-2-One shows its stripes not in ad copy but in grant-winning innovation, cleaner reactions, safer operation, and direct route to the results chemists want. Its long-standing place across organic, medicinal, and industrial labs doesn’t rest on buzzwords, but on honest performance under real-life bench conditions.
